One stop screening for multiple cancers (What could go wrong?)

http://www.ncbi.nlm.nih.gov/pubmed/23312963

Eur J Intern Med. 2013 Jan 8. pii: S0953-6205(12)00337-8. doi: 10.1016/j.ejim.2012.12.012. [Epub ahead of print]

One stop screening for multiple cancers: The experience of an integrated cancer prevention center.

Sella T, Boursi B, Gat-Charlap A, Aroch I, Liberman E, Moshkowitz M, Miller E, Gur E, Inbar R, Blachar A, Mabjeesh NJ, Rosenfeld O, Sperber F, Reiser V,Kleinman S, Jaffa AJ, Bloch M, Ormianer M, Naumov I, Kazanov D, Kraus S, Galazan L, Arber N.

Source

The Integrated Cancer Prevention Center, Tel-Aviv Sourasky Medical Center affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Abstract

BACKGROUND:

Cancer is a leading cause of mortality worldwide. Screening is a key strategy for reducing cancer morbidity and mortality.

METHODS:

We aimed to describe the experience of an integrated cancer prevention center in screening an asymptomatic population for the presence of neoplasia. One-thousand consecutive asymptomatic, apparently healthy adults, aged 20-80 years, were screened for early detection of 11 common cancers that account for 70-80% of cancer mortality.

RESULTS:

Malignant and benign lesions were found in 2.4% and 7.1% of the screenees, respectively. The most common malignant lesions were in the gastrointestinal tract and breast followed by gynecological and skin. The compliance rate for the different screening procedures was considerably higher than the actual screening rate in the general Israeli population - 78% compared to 60% for mammography (p<0.001) and 39% compared to 16% for colonoscopy (p<0.001). Advanced age, family history of cancer and certain lifestyle parameters were associated with increased risk. Moreover, polymorphisms in the APC and CD24 genes indicated high cancer risk. When two of the polymorphisms existed in an individual, the risk for a neoplastic lesion was extremely high (OR 2.3 [95% CI 0.94-5.9]).

CONCLUSIONS:

One stop shop screening for 11 common cancers in the setting of a multidisciplinary outpatient clinic is feasible and can detect cancer at an early stage.